USANA Health Sciences, Inc. (USNA)
- Previous Close
44.75 - Open
44.44 - Bid --
- Ask --
- Day's Range
43.34 - 44.67 - 52 Week Range
42.59 - 69.60 - Volume
80,066 - Avg. Volume
85,296 - Market Cap (intraday)
840.81M - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
13.24 - EPS (TTM)
3.30 - Earnings Date Apr 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
56.50
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
www.usana.com1,800
Full Time Employees
December 30
Fiscal Year Ends
Sector
Industry
Recent News: USNA
Performance Overview: USNA
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USNA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USNA
Valuation Measures
Market Cap
840.81M
Enterprise Value
518.45M
Trailing P/E
13.24
Forward P/E
15.90
PEG Ratio (5yr expected)
1.32
Price/Sales (ttm)
0.92
Price/Book (mrq)
1.69
Enterprise Value/Revenue
0.56
Enterprise Value/EBITDA
4.21
Financial Highlights
Profitability and Income Statement
Profit Margin
6.93%
Return on Assets (ttm)
9.46%
Return on Equity (ttm)
13.69%
Revenue (ttm)
921.01M
Net Income Avi to Common (ttm)
63.79M
Diluted EPS (ttm)
3.30
Balance Sheet and Cash Flow
Total Cash (mrq)
330.42M
Total Debt/Equity (mrq)
2.66%
Levered Free Cash Flow (ttm)
61.35M
Research Analysis: USNA
Company Insights: USNA
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: USNA
USNA: Raising target price to $47.00
USANA HEALTH SCIENCES INC has an Investment Rating of HOLD; a target price of $47.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetUSNA: Lowering target price to $45.00
USANA HEALTH SCIENCES INC has an Investment Rating of HOLD; a target price of $45.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetUSNA: Raising target price to $50.00
USANA HEALTH SCIENCES INC has an Investment Rating of HOLD; a target price of $50.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetUSNA: Lowering target price to $49.00
USANA HEALTH SCIENCES INC has an Investment Rating of HOLD; a target price of $49.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target